Predictors and prognosticators of outcomes in alcoholic hepatitis: A retrospective single center study

Table 1 Demographics and clinical data

	Full sample mean (SD/%)	Steroid sub-sample mean (SD/%)
N	425	126
Age	47.97 (11.95)	49.17 (10.95)
Sex (female)	32.0	30.2
Race	White: 70.8; Black: 14.8; Other: 14.4	White: 78.6; Black: 7.1; Other: 14.3
BMI	27.68 (6.63)	29.17 (7.84)
History of cirrhosis	56.7	86.5
History of hep C	13.6	12.7
History of hep B	2.4	1.6
History of diabetes	17.2	19.0
History of hyperlipidemia	24.7	19.0
History of hypertension	63.1	61.1
History of chronic kidney disease	9.4	11.1
Length of stay (days)	10.11 (8.43)	14.44 (9.56)
Encephalopathy	34.6	52.4
GI bleeding	19.8	30.2
Acute kidney injury	22.6	32.5
Hepatorenal syndrome	8.7	17.5
Ascites	24.0	43.7
Infection	30.2	42.1
Readmission	52.0	54.0
Mortality at 28 days	11.8	19.8
Mortality at 90 days	15.3	27.0
Nutrition consult	26.6	37.3
Albumin day 1	3.55 (0.91)	3.07 (0.74)
Albumin change day 1 to day 7	No data	-0.25 (0.63)
Daily mean percent meal intake	64.93 (25.62)	55.05 (25.41)
Grams of alcohol per day	210.25 (165.97)	228.15 (174.79)
Standard drinks per day	15.01 (11.85)	16.30 (12.48)

BMI: Body mass index.